Find clinical trials for Non-Small-Cell Lung Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Hanyang, Seoul, KOR:
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Seoul, Korea, Republic of and 64 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
Seoul, Korea, Republic of and 11 other locations
This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell...
Phase 2
Seoul, Korea, Republic of and 47 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Seoul, Korea, Republic of and 83 other locations
, HER3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous...
Phase 1
Seoul, Korea, Republic of and 21 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Seoul, Korea, Republic of and 23 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Seoul, Korea, Republic of and 205 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Seoul, Korea, Republic of and 123 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 2
Seoul, Korea, Republic of and 29 other locations
This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...
Phase 3
Seoul, Korea, Republic of and 170 other locations
Clinical trials
Research sites
Resources
Legal